Search

everythinglearnresearchcommunity

for

Search:↓

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

Active treatment can help prevent scarring hair loss in SLE patients.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Genetic testing for EGFR mutations is crucial in similar cases.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

A baby with KID syndrome died from infections and organ failure at 18 months old.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

LEF1 is essential for the development of airway glands and is regulated by the Wnt/ß-catenin pathway.

Parents often claim to use more home safety measures than they actually do.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 infection may trigger alopecia areata in some patients.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.